ABC signs former 'Lost' showrunner Carlton Cuse to multi-year deal to create new showsWalt Disney Co. TV network ABC said on Wednesday it's signed a multi-year deal with former "Lost" co-showrunner Carlton Cuse to create and produce new shows across all network, cable and streaming platforms. The news comes days after "Grey's Anatomy" and "Scandal" creator Shonda Rhimes was poached by Netflix Inc. from ABC, which was expected to be a blow to the network. "Forming a partnership with a writer/producer/director as talented and prolific as Carlton Cuse is a major victory for ABC Studios," president of ABC Studios Patrick Moran said in a statement. The Hollywood Reported wrote that the deal is said to be a worth more than $20 million, plus a percentage of the back-end on programming created under the partnership. Cuse spent six years at ABC with "Lost" and has since created shows such as "Bates Motel" and "The Strain." His current show "The Colony" was recently renewed for a second season on USA, and he also wrote the screenplay for "San Andreas," starring Dwayne Johnson. This new partnership comes as Disney gears up to launch its own stand alone streaming service to house its content by 2019. "I am very excited to be working alongside wonderful and iconic Disney brands like Marvel, Pixar and Lucasfilm to create and bring entertaining and compelling stories to the screen." Cuse said in a statement. "The very best part of my job is working with other writers to come up with cool ideas, solve story problems and get stories made." Shares of Disney are down 2% in the year to date, while the S&P 500 index is up more than 10%.

More than half of women who got an abortion last year were using contraception Human error and difficulty getting a new supply can contribute to contraceptive failureContraception like condoms, birth control pills and IUDs usually work, but they don’t always work.

History suggests Trump is vulnerable in 2020 The sharks are starting to circleHistory suggests that Donald Trump will face a stiff challenge in 2020 from someone in his own party. It also suggests he won’t be re-elected, writes Paul Brandus.

Opioids are ravaging the U.S., but they’re still the best pain drug we’ve got Some promising new medications to treat pain without opioids are being developed, but few have made it to market yetThe quest has seemed so elusive that it regularly draws comparison to the Holy Grail and unicorns.

Bitcoin retreats from all-time high even as Fidelity debuts digital-currency tracking Bitcoin has surged by 250% so far in 2017Bitcoin pulls back from its recent record on Wednesday, but the cryptocurrency enjoys some good news on the day, with Fidelity Investments announcing that it would feature tracking of the digital unit for its clients.

Republicans’ shadow campaign for 2020 doesn’t inspire Pence, Kasich seen jockeying for presidential run if Trump faltersA lot of Republicans are quietly jockeying for position to run for president in 2020 in case Donald Trump stumbles or decides not to run.

Dow futures are down but individual Dow stocks suggest win streak set to continueAlthough Dow industrials futures are 14 down points ahead of Tuesday's open, suggesting the Dow Jones Industrial Average's win streak will be snapped at 10 sessions, an analysis of individual Dow components trading premarket suggests the streak of gains are set to continue. Of the 27 Dow components that have traded ahead of the open, 17 are gaining ground. Overall, the components' premarket moves suggests the Dow would be up 11.5 points. Among the biggest contributors to the Dow's move, shares of Boeing Inc. would add 8.8 points to the Dow, McDonald's Corp. would add 3.6 points and American Express Co. would add 2.7 points. Meanwhile, Shares of 3M Co. would shave off 3 points, Goldman Sachs Group Inc. would take away 2.9 points, Johnson & Johnson would detract 2.3 points and Apple Inc. would shave off 1.6 points.

Beneath the glow of stock-market records, darkly bearish trends are lurking Recent weeks have seen sharp drops in the percentage of stocks above their 50-day moving averagesMajor U.S. stock-market indexes are trading near record levels, but does that statistic simply mask an ominous picture that’s being painted behind the scenes?

Two-thirds of jobs in this city could be automated by 2035 The rest of the U.S. isn’t far behind Las VegasWhile the invasion of the robots may be most pronounced in Las Vegas, the rest of the U.S. isn’t far behind.

How each Dow stock contributed to the 22,000 milestone Boeing and McDonald’s shares gave the biggest boost, while IBM and Goldman were the biggest dragHere’s how shares of the 30 Dow industrials components contributed to the blue-chip barometer’s climb to the 22,000 milestone.

Foxconn’s history of broken promises casts a shadow on Wisconsin news Foxconn has reneged on promised deals in many countries and regions, including the U.S.News that the iPhone maker will open a plant in Wisconsin was much ballyhooed late Wednesday, but not everyone is cheering.

This fund strategist says there’s at least one way companies can survive Amazon’s onslaught Customer satisfaction is a differentiator in some industries, says ACSI Funds’ Kevin QuiggCustomer satisfaction is a differentiator in some industries, says ACSI Funds’ Kevin Quigg.

Starbucks’ Teavana stores are the latest casualty at the mall Starbucks shares sink more than 8% in Friday trading, with shares downgraded at StifelStarbucks said after close examination, it will close all 379 of its Teavana stores, making it the latest mall-based retailer to shutter.

‘Atomic Blonde’ shows — again — kick-ass roles for women are good for Hollywood The film, produced for $30 million, is expected to pull in $21 million at the box office in its opening weekendThere have been kick-ass heroines in Hollywood for decades: Sigourney Weaver in the “Alien” trilogy, Uma Thurman in “Kill Bill,” more recently Gal Gadot in “Wonder Woman” and Charlize Theron for much of her career.

Ignore the Obamacare fight in Congress and buy these 5 health-care stocks Plenty of reason to like health care as a long-term investment no matter what Congress doesRegardless of how the debate over repealing the Affordable Care Act plays out, there are plenty of reason to like health care as a long-term investment, says Jeff Reeves.

Biotech companies lose $21 billion in research funds amid political squabbling That equals the cost of developing 15 to 20 new drugsMichael Brush does the math and says that could have funded the development of 15 to 20 drugs.

Surprise: Those ‘great’ companies generally turn out to be meh ... or duds After all the hoopla, McKinsey finds that over the long run, most struggle to outperform the S&P 500Context and luck turns out to be a big part of the success of companies described in seminal business books like “In Search of Excellence” and “Good to Great.”

Foxconn pledges to build $10 billion state-of-the-art electronics plant in WisconsinFoxconn, a global electronics manufacturer best known for building Apple’s iPhones, will open a new factory in southeastern Wisconsin that the company says will initially employ 3,000, a figure that could eventually grow to 13,000 jobs.

Bitcoin may have reached a tipping point, now that ‘Downtown’ Josh Brown just invested What does it mean when a prominent investor and financial blogger dips a toe into the cryptocurrency market?When prominent financial blogger ‘Downtown’ Josh Brown announces that he is making his entree into the realm of digital currencies, it may be worth taking notice.

S&P 500, Nasdaq close at records as tech shares lead Netflix soars 14% to top S&P 500 gainersThe S&P 500 and the Nasdaq close at records on Tuesday as gains in tech stocks offset weakness in telecom services and energy shares.

Here’s why some say it’s time to tread carefully with Netflix shares Critical information for the U.S. trading dayBoom. Netflix is up about 11% in premarket after another set of blockbuster results. However, but some say much is backed into shares and it may be time to cash in on that big gain.

Johnson & Johnson tops profit estimates, but sales fall shortJohnson & Johnson shares rose 0.6% premarket after the company beat profit estimates for its second quarter, but fell short on sales. The consumer goods company said it had net income of $3.8 billion, or $1.40 a share, in the second quarter, down from $3.9 billion, or $1.43 a share, in the year-earlier period. Excluding one-time charges, per-share earnings came to $1.83, ahead of the FactSet consensus of $1.79. Sales rose to $18.8 billion from $18.5 billion, below the FactSet consensus of $18.9 billion. The company raised its guidance for the full year and now expects sales of $75.8 billion to $76.1 billion. The current FactSet consensus is for full-year sales of $75.7 billion. The company set EPS guidance for the year of $7.12 to $7.22 a share, compared with a FactSet consensus of $7.11. The stock is up 15% in 2017, while the Dow Jones Industrial Average has gained 9.5% and the S&P 500 has gained 10%.

Why the case for recession doesn’t add up Capacity’s not that tight, assets not that pricey, bull not that oldSome people are getting nervous, but Tim Mullaney writes that there’s no sign that the U.S. will enter a recession any time soon.

Johnson & Johnson earnings: A challenging second quarter poised for a turnaround The company may have more positive developments later this year, said a J.P. Morgan analystJohnson & Johnson’s first-quarter sales miss amid a challenging drug market disappointed investors. Don’t expect the company’s second-quarter earnings — scheduled before the open on July 18 — to be any different, Wall Street analysts say.

Stock market poised to ride stellar earnings to new heights ‘The canary in the coal mine is earnings and the canary is singing a very sweet song’ Another quarter of strong earnings could juice an already primed stock market, pushing key indexes to new records in coming weeks.

Oil ends higher to tally a gain of more than 5% for the week Nigeria supply setback, higher crude demand forecast lift pricesOil prices scores a fifth straight day of gains on Friday to score a weekly rise of more than 5%.

Stock market hasn’t been this quiet since Lyndon B. Johnson was president Stocks have posted an absolute average daily move of 0.32% in 2017The last time Wall Street trading was this quiet, Lyndon Johnson was president, The Sound of Music was the movie to see, and on the radio, the Rolling Stones were searching for satisfaction.

Trump Jr. emails should be ‘game over’ for this White House Direct contact between Trump campaign and Russia fails to move GOPContact between Trump campaign and Russia fails to move GOP, writes Chris Edelson.

Thanks ... Obama? Foreign firms slash U.S. ‘investment’ in 2016 Reduction tied to rules cracking down on corporate tax shelters Foreign businesses invested 15% less in the United States last year, but it’s not a sign America has suddenly become a less attractive place to invest.

Amazon is taking away the power of brand names, throwing another industry into turmoil Consumer packaged-goods companies are cutting back on marketing, signaling complacency, analyst saysAmazon Inc. is taking away the power of brand-name packaged-good products, analyst says, which he calls “a bad thing for the industry, consumers and the country.”

Most sunscreen products don’t actually work Watch out for overly high (or low) SPF values and read the list of ingredients closelyWatch out for overly high (or low) SPF values and read the list of ingredients closely.

Trump push for steel tariffs sparks worries about global trade war White House targets China, but other nations could retaliateAfter running on an “America First” theme in his 2016 campaign, President Donald Trump is eager to take action against China and other nations he accuses of unfair trade practices.

Here’s a sneaky way to get yourself better health insurance Trumpcare? Ryancare? Obamacare? Who cares?Trumpcare? Ryancare? Obamacare? Who cares? Brett Arends offers a different solution to paying for health care.

Intraday Data provided by SIX Financial Information and subject to terms of use. Historical and current end-of-day data provided by SIX Financial Information. All quotes are in local exchange time. Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. Intraday data delayed at least 15 minutes or per exchange requirements.